Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2
- Resource Type
- Article
- Source
- In
Vaccine 23 July 2014 32(34):4342-4348 - Subject
- Language
- ISSN
- 0264-410X